Biogen and Sage Therapeutics hold a joint investor webcast to discuss the planned commercialization approach and opportunity for their investigational product, Zuranolone, on December 6 at 8 am. Webcast Link
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on SAGE:
